Cargando…
The Interplay of Tumor Vessels and Immune Cells Affects Immunotherapy of Glioblastoma
Immunotherapies with immune checkpoint inhibitors or adoptive cell transfer have become powerful tools to treat cancer. These treatments act via overcoming or alleviating tumor-induced immunosuppression, thereby enabling effective tumor clearance. Glioblastoma (GBM) represents the most aggressive, p...
Autores principales: | Ghosh, Mitrajit, Lenkiewicz, Anna M., Kaminska, Bozena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496044/ https://www.ncbi.nlm.nih.gov/pubmed/36140392 http://dx.doi.org/10.3390/biomedicines10092292 |
Ejemplares similares
-
The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
por: Leone, Kevin, et al.
Publicado: (2018) -
Is Glioblastoma an Epigenetic Malignancy?
por: Maleszewska, Marta, et al.
Publicado: (2013) -
Tumor Vessels Fuel the Fire in Glioblastoma
por: Rosińska, Sara, et al.
Publicado: (2021) -
Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance
por: Agosti, Edoardo, et al.
Publicado: (2023) -
Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)
por: Dymicka-Piekarska, Violetta, et al.
Publicado: (2020)